Choose Your News
Loading...
Formal case counts can take days or weeks as doctors double-check symptoms against CDC guidelines. [Read More]
A boy who lost a large part of his brain's vision processing center has recovered much of his ability to recognize faces, thanks to brain... [Read More]
Doctors are prescribing benzodiazepines, like Xanax and Ativan, at skyrocketing rates. But most don't know about their debilitating, even deadly, effects. [Read More]
Approval would be the first product actually demonstrated to work... [Read More]
The Food and Drug Administration approved a blood test Wednesday that it says can help diagnose concussions more quickly, without the need for X-rays. [Read More]
The FDA has approved a new blood test to detect concussions, saying it will save many the need to have expensive CT scans. [Read More]
Emma Gibson was conceived in 1992 but born in 2017, 24 years later. Gibson, born in November, may be the oldest ever frozen embryo to... [Read More]
Police in Tennessee were investigating the scene of a church shooting early Sunday afternoon. Officials called it a "a mass casualty situation." [Read More]
Police in Tennessee were investigating the scene of a church shooting early Sunday afternoon. Officials called it a "a mass casualty situation." [Read More]
Fleeing a hurricane may be worse than sheltering in place for some people, including the frail and elderly, research shows. [Read More]
Fleeing a hurricane may be worse than sheltering in place for some people, including the frail and elderly, research shows. [Read More]
A new program aims to encourage obstetricians and OB/GYNs working in rural America, so women don't have to travel for hours to give birth in... [Read More]
The new FDA-approved drug, Gleolan, lights up brain tumors like Sen. John McCain' has, helping surgeons clear away malignant cells. [Read More]
The new FDA approved drug, Gleolin, "a game changer" according to experts, is helping surgeons to better visualize tumors making complete removal much easier. [Read More]
Loading...
Preview